What's interesting is not a single person has suggested how these 13 installment payments are being taken care of. Money ain't free. Maybe there is a Nasdaq rule that won't allow for this massive dilution all at once. I don't know. That wouldn't be good. What I do think is money ain't free and drugs 12 years into a a patent cycle don't become blockbuster due to some AI. There actually is an OTC product for ED that was approved last fall but all this great twitter DD isn't mentioning that.
What I don't understand is what the fascination is of the exact number of shares and why someone would stick to a more than 3 month old number when the filings are repeatedly shown regarding payment of the notes. If its 3 million or 8 doesn't matter if you can't pay your bills in cash or have to pay in stock. Sales are poor, patent expires in little over a year, and multiple Notes are due monthly and even yearly. I'm just pointing out the filings. If the company can't sell enough stock, that wouldn't really be a good thing would it?
Recent PTPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:32:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:07:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:06:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 10:05:30 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/30/2023 09:07:41 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/30/2023 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/15/2023 10:11:15 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 10:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:00:18 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/19/2023 08:36:46 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/15/2023 09:16:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:22:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/25/2023 09:08:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:03:50 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/15/2023 09:01:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:03:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/11/2023 08:31:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:41:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM